Chen Schor - Aug 14, 2023 Form 4 Insider Report for Adicet Bio, Inc. (ACET)

Signature
/s/ Nick Harvey, Attorney-in-Fact
Stock symbol
ACET
Transactions as of
Aug 14, 2023
Transactions value $
$0
Form type
4
Date filed
8/16/2023, 06:11 PM
Previous filing
May 25, 2023
Next filing
Oct 2, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ACET Stock Option (Right to Buy) Disposed to Issuer $0 -36.9K -100% $0.00* 0 Aug 14, 2023 Common Stock 36.9K $8.89 Direct F1, F2, F3
transaction ACET Stock Option (Right to Buy) Award $0 +36.9K $0.00 36.9K Aug 14, 2023 Common Stock 36.9K $2.14 Direct F2, F3, F4
transaction ACET Stock Option (Right to Buy) Disposed to Issuer $0 -872K -100% $0.00* 0 Aug 14, 2023 Common Stock 872K $16.11 Direct F2, F5
transaction ACET Stock Option (Right to Buy) Award $0 +872K $0.00 872K Aug 14, 2023 Common Stock 872K $2.14 Direct F2, F4, F5
transaction ACET Stock Option (Right to Buy) Disposed to Issuer $0 -240K -100% $0.00* 0 Aug 14, 2023 Common Stock 240K $13.27 Direct F2, F6
transaction ACET Stock Option (Right to Buy) Award $0 +240K $0.00 240K Aug 14, 2023 Common Stock 240K $2.14 Direct F2, F4, F6
transaction ACET Stock Option (Right to Buy) Disposed to Issuer $0 -422K -100% $0.00* 0 Aug 14, 2023 Common Stock 422K $16.82 Direct F2, F7
transaction ACET Stock Option (Right to Buy) Award $0 +422K $0.00 422K Aug 14, 2023 Common Stock 422K $2.14 Direct F2, F4, F7
transaction ACET Stock Option (Right to Buy) Disposed to Issuer $0 -295K -100% $0.00* 0 Aug 14, 2023 Common Stock 295K $15.52 Direct F2, F8
transaction ACET Stock Option (Right to Buy) Award $0 +295K $0.00 295K Aug 14, 2023 Common Stock 295K $2.14 Direct F2, F4, F8
transaction ACET Stock Option (Right to Buy) Disposed to Issuer $0 -385K -100% $0.00* 0 Aug 14, 2023 Common Stock 385K $9.05 Direct F2, F9
transaction ACET Stock Option (Right to Buy) Award $0 +385K $0.00 385K Aug 14, 2023 Common Stock 385K $2.14 Direct F2, F4, F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects 1-for-7 reverse stock split effected by the Issuer on September 15, 2020.
F2 On August 8, 2023, the Issuer's Board of Directors approved an option repricing (the "Repricing"), effective as of August 14, 2023 (the "Effective Date"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable.
F3 The shares subject to this option are fully vested and exercisable as of the date hereof.
F4 The exercise price of the option is $2.14 per share, representing the fair market value per share of the Issuer's Common Stock on the Effective Date; provided that the repriced option will revert to its original exercise price if, prior to the first anniversary of the Effective Date, (a) the Reporting Person's employment is terminated by the Issuer with cause or by the Reporting Person or (b) the option is exercised.
F5 The shares subject to this option shall vest in forty-eight (48) equal installments on each monthly anniversary following September 17, 2020, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date.
F6 The shares subject to this option shall vest in forty-eight (48) equal installments on each monthly anniversary following January 13, 2021, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date.
F7 The shares subject to this option shall vest in forty-eight (48) equal installments on each monthly anniversary following February 12, 2021, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date.
F8 The shares subject to this option shall vest in forty-eight (48) equal installments on each monthly anniversary following January 7, 2022, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date.
F9 The shares subject to this option shall vest in forty-eight (48) equal installments on each monthly anniversary following January 24, 2023, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date.